CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on optimizing hyperthermia treatment for cancer by integrating it with radiotherapy and chemotherapy. It aims to develop a planning platform that personalizes treatment delivery based on biological mechanisms, enhancing clinical outcomes for patients.
Hyperthermia (HT), heating tumors to temperatures of 40-44°C, is an oncological treatment used in combination withradiotherapy (RT) and chemotherapy to enhance their efficacy.
Clinical effectiveness of HT has been demonstrated inrandomised studies and HT is currently applied for many clinical indications, like cervical cancer and recurrent breast cancer.Clinical results can be further improved as application of HT with well-controlled tumor temperatures and optimal timing andsequence realising f…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, Aarhus C
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Zurich
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Erlangen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Winterthur
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
